Gil Morgan May 26
Just out📣 🇺🇸Approves nivolumab+ipilimumab🧪 Combo w/Limited as1️⃣st Line Treatment of Metastatic or Recurrent ‼️ This marks the6️⃣th indication for this combo across5️⃣types of ⚠️ ®-nivolumab